Annual Shareholders Equity
$48.15 M
-$18.43 M-27.68%
31 December 2023
Summary:
Lisata Therapeutics annual stockholders equity is currently $48.15 million, with the most recent change of -$18.43 million (-27.68%) on 31 December 2023. During the last 3 years, it has fallen by -$44.11 million (-47.81%). LSTA annual shareholders equity is now -47.81% below its all-time high of $92.25 million, reached on 31 December 2021.LSTA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$33.69 M
-$4.56 M-11.92%
30 September 2024
Summary:
Lisata Therapeutics quarterly stockholders equity is currently $33.69 million, with the most recent change of -$4.56 million (-11.92%) on 30 September 2024. Over the past year, it has dropped by -$14.46 million (-30.03%). LSTA quarterly shareholders equity is now -69.45% below its all-time high of $110.27 million, reached on 01 March 2021.LSTA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSTA Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -30.0% |
3 y3 years | -47.8% | -63.5% |
5 y5 years | +131.3% | +61.9% |
LSTA Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -47.8% | at low | -63.5% | at low |
5 y | 5 years | -47.8% | +131.3% | -69.5% | +95.4% |
alltime | all time | -47.8% | +2592.4% | -69.5% | +1435.0% |
Lisata Therapeutics Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $33.69 M(-11.9%) |
June 2024 | - | $38.25 M(-11.0%) |
Mar 2024 | - | $43.00 M(-10.7%) |
Dec 2023 | $48.15 M(-27.7%) | $48.15 M(-9.1%) |
Sept 2023 | - | $52.96 M(-8.6%) |
June 2023 | - | $57.97 M(-4.9%) |
Mar 2023 | - | $60.96 M(-8.4%) |
Dec 2022 | $66.58 M(-27.8%) | $66.58 M(-7.6%) |
Sept 2022 | - | $72.03 M(-12.6%) |
June 2022 | - | $82.39 M(-6.9%) |
Mar 2022 | - | $88.50 M(-4.1%) |
Dec 2021 | $92.25 M(+183.9%) | - |
Dec 2021 | - | $92.25 M(-6.5%) |
Sept 2021 | - | $98.67 M(-6.0%) |
June 2021 | - | $104.93 M(-4.8%) |
Mar 2021 | - | $110.27 M(+239.3%) |
Dec 2020 | $32.50 M(+56.1%) | $32.50 M(-13.9%) |
Sept 2020 | - | $37.74 M(+11.6%) |
June 2020 | - | $33.81 M(+96.1%) |
Mar 2020 | - | $17.24 M(-17.2%) |
Dec 2019 | $20.82 M(-44.8%) | $20.82 M(-17.6%) |
Sept 2019 | - | $25.25 M(-15.5%) |
June 2019 | - | $29.89 M(-13.9%) |
Mar 2019 | - | $34.73 M(-7.9%) |
Dec 2018 | $37.73 M(-25.3%) | $37.73 M(-8.2%) |
Sept 2018 | - | $41.08 M(-6.1%) |
June 2018 | - | $43.74 M(-4.1%) |
Mar 2018 | - | $45.59 M(-9.7%) |
Dec 2017 | $50.51 M(+934.2%) | $50.51 M(-5.3%) |
Sept 2017 | - | $53.33 M(-2.0%) |
June 2017 | - | $54.42 M(-6980.0%) |
Mar 2017 | - | -$791.00 K(-116.2%) |
Dec 2016 | $4.88 M(-79.4%) | $4.88 M(-54.6%) |
Sept 2016 | - | $10.75 M(+77.6%) |
June 2016 | - | $6.05 M(-55.7%) |
Mar 2016 | - | $13.66 M(-42.4%) |
Dec 2015 | $23.71 M(-59.5%) | $23.71 M(-57.2%) |
Sept 2015 | - | $55.43 M(-16.5%) |
June 2015 | - | $66.38 M(+31.7%) |
Mar 2015 | - | $50.40 M(-13.9%) |
Dec 2014 | $58.51 M(-6.4%) | $58.51 M(-7.1%) |
Sept 2014 | - | $63.00 M(-19.3%) |
June 2014 | - | $78.04 M(+30.8%) |
Mar 2014 | - | $59.64 M(-4.6%) |
Dec 2013 | $62.54 M(+88.5%) | $62.54 M(+75.2%) |
Sept 2013 | - | $35.70 M(+6.7%) |
June 2013 | - | $33.46 M(+13.7%) |
Mar 2013 | - | $29.43 M(-11.3%) |
Dec 2012 | $33.18 M(-46.5%) | $33.18 M(-31.2%) |
Sept 2012 | - | $48.21 M(+4.0%) |
June 2012 | - | $46.35 M(-26.9%) |
Mar 2012 | - | $63.37 M(+2.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $62.03 M(+27.5%) | $62.03 M(-15.7%) |
Sept 2011 | - | $73.56 M(+17.7%) |
June 2011 | - | $62.51 M(-3.8%) |
Mar 2011 | - | $65.00 M(+33.6%) |
Dec 2010 | $48.66 M(+103.5%) | $48.66 M(+6.6%) |
Sept 2010 | - | $45.64 M(-4.5%) |
June 2010 | - | $47.80 M(+59.7%) |
Mar 2010 | - | $29.93 M(+25.2%) |
Dec 2009 | $23.91 M(+2670.3%) | $23.91 M(-1418.1%) |
Sept 2009 | - | -$1.81 M(-147.8%) |
June 2009 | - | $3.79 M(-571.8%) |
Mar 2009 | - | -$804.40 K(-193.2%) |
Dec 2008 | $863.20 K(-74.0%) | $863.20 K(-52.8%) |
Sept 2008 | - | $1.83 M(+5.6%) |
June 2008 | - | $1.73 M(-18.1%) |
Mar 2008 | - | $2.11 M(-36.2%) |
Dec 2007 | $3.32 M(+1035.3%) | $3.32 M(-18.4%) |
Sept 2007 | - | $4.07 M(+2382.1%) |
June 2007 | - | $163.80 K(-88.0%) |
Mar 2007 | - | $1.36 M(+365.8%) |
Dec 2006 | $292.10 K(-116.1%) | $292.10 K(-78.9%) |
Sept 2006 | - | $1.39 M(-223.8%) |
June 2006 | - | -$1.12 M(+9.9%) |
Mar 2006 | - | -$1.02 M(-44.0%) |
Dec 2005 | -$1.82 M(-5.9%) | -$1.82 M(-28.0%) |
Sept 2005 | - | -$2.52 M(+9.9%) |
June 2005 | - | -$2.30 M(+10.6%) |
Mar 2005 | - | -$2.08 M(+7.4%) |
Dec 2004 | -$1.93 M(+28.5%) | -$1.93 M(+15.5%) |
Sept 2004 | - | -$1.67 M(-12.3%) |
June 2004 | - | -$1.91 M(+3.4%) |
Mar 2004 | - | -$1.84 M(+22.7%) |
Dec 2003 | -$1.50 M(+82.4%) | -$1.50 M(+10.7%) |
Sept 2003 | - | -$1.36 M(+14.4%) |
June 2003 | - | -$1.19 M(+23.4%) |
Mar 2003 | - | -$961.80 K(+16.7%) |
Dec 2002 | -$823.90 K(-320.5%) | -$823.90 K(+85.4%) |
Sept 2002 | - | -$444.40 K(+108.1%) |
June 2002 | - | -$213.50 K(-750.9%) |
Mar 2002 | - | $32.80 K(-91.2%) |
Dec 2001 | $373.70 K(-84.7%) | $373.70 K(-65.9%) |
Sept 2001 | - | $1.10 M(-25.3%) |
June 2001 | - | $1.47 M(-18.7%) |
Mar 2001 | - | $1.81 M(-26.2%) |
Dec 2000 | $2.45 M(-37.5%) | $2.45 M(-33.3%) |
Sept 2000 | - | $3.67 M(-20.4%) |
June 2000 | - | $4.61 M(-9.6%) |
Mar 2000 | - | $5.10 M |
Dec 1999 | $3.92 M(-1374.3%) | - |
Dec 1998 | -$307.80 K(+1182.5%) | - |
Mar 1998 | -$24.00 K(-96.3%) | - |
Mar 1997 | -$651.70 K(+104.2%) | - |
Mar 1996 | -$319.10 K | - |
FAQ
- What is Lisata Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Lisata Therapeutics?
- What is Lisata Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Lisata Therapeutics?
- What is Lisata Therapeutics quarterly shareholders equity year-on-year change?
What is Lisata Therapeutics annual stockholders equity?
The current annual shareholders equity of LSTA is $48.15 M
What is the all time high annual shareholders equity for Lisata Therapeutics?
Lisata Therapeutics all-time high annual stockholders equity is $92.25 M
What is Lisata Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of LSTA is $33.69 M
What is the all time high quarterly shareholders equity for Lisata Therapeutics?
Lisata Therapeutics all-time high quarterly stockholders equity is $110.27 M
What is Lisata Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, LSTA quarterly stockholders equity has changed by -$14.46 M (-30.03%)